Resources
Resources
Our Evidence Base
Rapid and sustained reduction of treatment-resistant PTSD symptoms after intravenous ketamine in a real-world, psychedelic paradigm
Henry A MacConnel, Mitch Earleywine, and Steven Radowitz
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial
Jennifer M Mitchell, Marcela Ot’alora G, Bessel van der Kolk, Scott Shannon, Michael Bogenschutz, Yevgeniy Gelfand, Casey Paleos, Christopher R Nicholas, Sylvestre Quevedo, Brooke Balliett, Scott Hamilton, Michael Mithoefer, Sarah Kleiman, Kelly Parker-Guilbert, Keren Tzarfaty, Charlotte Harrison, Alberdina de Boer, Rick Doblin, Berra Yazar-Klosinski; MAPP2 Study Collaborator Group
Single-Dose Psilocybin Treatment for Major Depressive Disorder
A Randomized Clinical Trial
Charles L. Raison, MD; Gerard Sanacora, MD, PhD; Joshua Woolley, MD, PhD; Keith Heinzerling, MD; Boadie W. Dunlop, MD, MS; Randall T. Brown, MD, PhD; Rishi Kakar, MD; Michael Hassman, DO; Rupal P. Trivedi, MD; Reid Robison, MD; Natalie Gukasyan, MD; Sandeep M. Nayak, MD; Xiaojue Hu, MD; Kelley C. O’Donnell, MD, PhD; Benjamin Kelmendi, MD; Jordan Sloshower, MD, MS; et al
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression
Guy M. Goodwin, F.Med.Sci., Scott T. Aaronson, M.D., Oscar Alvarez, M.R.C.Psych., Peter C. Arden, M.P.H., Annie Baker, R.G.N., James C. Bennett, M.Sc., Catherine Bird, M.Sc., Ekaterina Malievskaia, M.D., +66
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder
A Randomized Clinical Trial
Michael P. Bogenschutz, MD; Stephen Ross, MD; Snehal Bhatt, MD; Tara Baron, MA; Alyssa A. Forcehimes, PhD; Eugene Laska, PhD; Sarah E. Mennenga, PhD; Kelley O’Donnell, MD, PhD1; Lindsey T. Owens, MA; Samantha Podrebarac, MA; John Rotrosen, MD; J. Scott Tonigan, PhD; Lindsay Worth, MA
Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis
Yazen Alnefeesi, David Chen-Li, Ella Krane, Muhammad Youshay Jawad, Nelson B. Rodrigues, Felicia Ceban, Joshua D. Di Vincenzo, Shakila Meshkat, Roger C.M. Ho, Hartej Gill, Kayla M. Teopiz, Bing Cao, Yena Lee, Roger S. McIntyre, Joshua D. Rosenblat
Ketamine Assisted Psychotherapy: A Systematic Narrative Review of the Literature
Sandra J Drozdz, Akash Goel, Matthew W McGarr, Joel Katz, Paul Ritvo, Gabriella F Mattina, Venkat Bhat, Calvin Diep & Karim S Ladha
Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy
Jennifer Dore, Brent Turnipseed, Shannon Dwyer, Andrea Turnipseed, Julane Andries, German Ascani, Celeste Monnette, Angela Huidekoper, Nicole Strauss, Phil Wolfson
Providers
Learn how to become a clinic in the Beckley Clinical Network →
Health Plans
Learn more about Beckley Clinical solutions and expand access to safe and effective psychedelic treatment to your members →
Investors
Get in touch with our Investor Relations team today →